The high incidence of vascular thromboembolic events (VTE) in advanced urothelial cancer (UC) patients (pts) treated with carboplatin (Cb): Analysis of treatment with gemcitabine (G)/cb (GCb), gcb/bevacizumab (GCbBev), or gemcitabine/cisplatin (GCis).
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Christopher Michael Tully, Andrea Borghese Apolo, Emily C. Zabor, Ashley Marie Regazzi, Irina Ostrovnaya, Jonathan E. Rosenberg, Dean F. Bajorin
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2590142199